Semax

Semax is a research-grade synthetic heptapeptide derived from the 4-7 fragment of adrenocorticotropic hormone (ACTH), modified with a Pro-Gly-Pro tripeptide extension to enhance stability and bioactivity. Recognized as one of the most extensively studied nootropic peptides in Russian neuroscience,

Semax is notable for its capability to upregulate brain-derived neurotrophic factor (BDNF) and modulate central neurotransmitter systems, including dopamine, serotonin, and acetylcholine. This peptide is provided in lyophilised powder form, with a purity of 99% or higher, suitable for scientific research. It is supplied in a 10mg package and must be stored at -20°C, protected from light and moisture to preserve its integrity.

Research applications include:

• Investigation of BDNF upregulation and neurotrophic pathway modulation
• Studies on cognitive functions such as memory and learning
• Analysis of neuroprotective mechanisms against hypoxia and oxidative stress
• Research on neurotransmitter system modulation, including dopaminergic, serotonergic, and cholinergic pathways
• Examination of enkephalin degradation inhibition and endogenous opioid pathways
• Comparison of nootropic peptides, including studies contrasting Semax with other compounds like Selank

Product specifications:

• Form: Lyophilised powder
• Purity: ≥99%
• Storage: -20°C, protected from light and moisture
• Available strength: 10 mg

⚠ For research purposes only. This product is not intended for human or veterinary use, consumption, or self-administration. It must be handled solely by qualified professionals within a laboratory setting. This peptide has not been evaluated by regulatory authorities for therapeutic applications. Use exclusively for scientific research involving nootropic peptides like Semax.